The Boston-Cambridge area is one of the most established biotech hubs globally, bringing together leading universities, innovative biotech companies, and major pharmaceutical players in a single ecosystem. Massachusetts employs over 140,000 people in the life sciences and consistently attracts a significant share of U.S. biotech venture funding. With nearly 1,000 biotech companies in the region, it offers exceptional access to talent, innovation, and partnership opportunities across the full drug development lifecycle.
Our Waltham facility, dedicated to protein-based biologics, provides a seamless, vertically integrated pathway from cell line development through cGMP manufacturing of drug substance and drug product. We offer the flexibility of both mammalian and microbial expression platforms, designed to support a broad range of recombinant proteins and monoclonal antibodies. Every project is underpinned by rigorous quality systems and integrated analytical workflows, supported by meticulous documentation to move your program forward with confidence.
R&D laboratories
Microbial fermenters
Mammalian bioreactors (single-use)
Drug Substance and Drug Product
Vials, Pre-Filled Syringes, Cartridges, Lyophilization
Our EU and US sites operate as one, same capabilities, same standards, full regulatory flexibility.
